Warning letter
Formology Lab Inc.: warning letter of Mar 1, 2023
FDA warning letter 644745 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 644745 |
|---|---|
| Company | Formology Lab Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Mar 1, 2023 |
| Posted date | Mar 14, 2023 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 211.84(d)(1), 211.22(a), 211.100(a) |
| Inspection city | Chatsworth |
| Inspection ZIP | 91311 |
| Inspection start date | Aug 30, 2022 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: